vs
Side-by-side financial comparison of LCNB CORP (LCNB) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
LCNB CORP is the larger business by last-quarter revenue ($23.9M vs $18.3M, roughly 1.3× ROCKWELL MEDICAL, INC.). LCNB CORP runs the higher net margin — 23.7% vs -3.0%, a 26.7% gap on every dollar of revenue. On growth, LCNB CORP posted the faster year-over-year revenue change (5.1% vs -25.6%). LCNB CORP produced more free cash flow last quarter ($33.4M vs $2.2M). Over the past eight quarters, LCNB CORP's revenue compounded faster (15.7% CAGR vs -10.1%).
LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
LCNB vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.9M | $18.3M |
| Net Profit | $5.7M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 29.2% | -2.2% |
| Net Margin | 23.7% | -3.0% |
| Revenue YoY | 5.1% | -25.6% |
| Net Profit YoY | -7.6% | 26.7% |
| EPS (diluted) | $0.40 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.9M | $18.3M | ||
| Q3 25 | $23.8M | $15.9M | ||
| Q2 25 | $22.8M | $16.1M | ||
| Q1 25 | $21.5M | $18.9M | ||
| Q4 24 | $22.7M | $24.7M | ||
| Q3 24 | $21.4M | $28.3M | ||
| Q2 24 | $19.3M | $25.8M | ||
| Q1 24 | $17.8M | $22.7M |
| Q4 25 | $5.7M | $-554.0K | ||
| Q3 25 | $6.9M | $-1.8M | ||
| Q2 25 | $5.9M | $-1.5M | ||
| Q1 25 | $4.6M | $-1.5M | ||
| Q4 24 | $6.1M | $-756.0K | ||
| Q3 24 | $4.5M | $1.7M | ||
| Q2 24 | $925.0K | $343.0K | ||
| Q1 24 | $1.9M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 29.2% | -2.2% | ||
| Q3 25 | 35.6% | -9.9% | ||
| Q2 25 | 31.6% | -8.4% | ||
| Q1 25 | 25.6% | -7.2% | ||
| Q4 24 | 32.9% | -2.1% | ||
| Q3 24 | 24.9% | 6.8% | ||
| Q2 24 | 4.9% | 2.0% | ||
| Q1 24 | 12.5% | -5.8% |
| Q4 25 | 23.7% | -3.0% | ||
| Q3 25 | 29.1% | -11.0% | ||
| Q2 25 | 26.0% | -9.3% | ||
| Q1 25 | 21.4% | -8.0% | ||
| Q4 24 | 27.0% | -3.1% | ||
| Q3 24 | 21.2% | 5.9% | ||
| Q2 24 | 4.8% | 1.3% | ||
| Q1 24 | 10.7% | -7.6% |
| Q4 25 | $0.40 | $-0.01 | ||
| Q3 25 | $0.49 | $-0.05 | ||
| Q2 25 | $0.41 | $-0.05 | ||
| Q1 25 | $0.33 | $-0.04 | ||
| Q4 24 | $0.44 | $-0.02 | ||
| Q3 24 | $0.31 | $0.04 | ||
| Q2 24 | $0.07 | $0.01 | ||
| Q1 24 | $0.15 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $21.6M | $10.7M |
| Total DebtLower is stronger | $104.4M | — |
| Stockholders' EquityBook value | $273.9M | $37.0M |
| Total Assets | $2.2B | $57.1M |
| Debt / EquityLower = less leverage | 0.38× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.6M | $10.7M | ||
| Q3 25 | $35.9M | $13.6M | ||
| Q2 25 | $49.8M | $12.5M | ||
| Q1 25 | $37.7M | $11.4M | ||
| Q4 24 | $35.7M | $15.7M | ||
| Q3 24 | $39.4M | $12.3M | ||
| Q2 24 | $34.9M | $11.9M | ||
| Q1 24 | $33.0M | $6.6M |
| Q4 25 | $104.4M | — | ||
| Q3 25 | $104.7M | — | ||
| Q2 25 | $105.0M | — | ||
| Q1 25 | $104.6M | — | ||
| Q4 24 | $155.2M | — | ||
| Q3 24 | $155.7M | — | ||
| Q2 24 | $162.2M | — | ||
| Q1 24 | $162.6M | — |
| Q4 25 | $273.9M | $37.0M | ||
| Q3 25 | $269.9M | $37.0M | ||
| Q2 25 | $263.5M | $30.4M | ||
| Q1 25 | $258.7M | $31.5M | ||
| Q4 24 | $253.0M | $32.6M | ||
| Q3 24 | $253.2M | $29.1M | ||
| Q2 24 | $245.2M | $23.5M | ||
| Q1 24 | $233.7M | $20.6M |
| Q4 25 | $2.2B | $57.1M | ||
| Q3 25 | $2.2B | $57.5M | ||
| Q2 25 | $2.3B | $52.6M | ||
| Q1 25 | $2.3B | $54.0M | ||
| Q4 24 | $2.3B | $59.2M | ||
| Q3 24 | $2.3B | $57.1M | ||
| Q2 24 | $2.4B | $53.0M | ||
| Q1 24 | $2.3B | $50.7M |
| Q4 25 | 0.38× | — | ||
| Q3 25 | 0.39× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | 0.40× | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 0.61× | — | ||
| Q2 24 | 0.66× | — | ||
| Q1 24 | 0.70× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.4M | $2.3M |
| Free Cash FlowOCF − Capex | $33.4M | $2.2M |
| FCF MarginFCF / Revenue | 140.2% | 12.0% |
| Capex IntensityCapex / Revenue | 4.0% | 0.5% |
| Cash ConversionOCF / Net Profit | 6.08× | — |
| TTM Free Cash FlowTrailing 4 quarters | $54.5M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.4M | $2.3M | ||
| Q3 25 | $14.0M | $-1.3M | ||
| Q2 25 | $5.5M | $1.8M | ||
| Q1 25 | $2.2M | $-3.5M | ||
| Q4 24 | $93.2M | $865.0K | ||
| Q3 24 | $11.9M | $4.3M | ||
| Q2 24 | $54.9M | $1.4M | ||
| Q1 24 | $-11.9M | $-2.4M |
| Q4 25 | $33.4M | $2.2M | ||
| Q3 25 | $13.7M | $-1.5M | ||
| Q2 25 | $5.2M | $1.7M | ||
| Q1 25 | $2.1M | $-3.5M | ||
| Q4 24 | $89.4M | $470.0K | ||
| Q3 24 | $10.5M | $4.1M | ||
| Q2 24 | $53.8M | $1.2M | ||
| Q1 24 | $-12.8M | $-2.5M |
| Q4 25 | 140.2% | 12.0% | ||
| Q3 25 | 57.4% | -9.6% | ||
| Q2 25 | 23.0% | 10.5% | ||
| Q1 25 | 10.0% | -18.8% | ||
| Q4 24 | 394.0% | 1.9% | ||
| Q3 24 | 49.0% | 14.4% | ||
| Q2 24 | 278.6% | 4.5% | ||
| Q1 24 | -71.8% | -11.1% |
| Q4 25 | 4.0% | 0.5% | ||
| Q3 25 | 1.3% | 1.4% | ||
| Q2 25 | 1.0% | 1.0% | ||
| Q1 25 | 0.3% | 0.3% | ||
| Q4 24 | 16.7% | 1.6% | ||
| Q3 24 | 6.7% | 0.7% | ||
| Q2 24 | 5.9% | 1.1% | ||
| Q1 24 | 4.8% | 0.6% |
| Q4 25 | 6.08× | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 0.92× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 15.23× | — | ||
| Q3 24 | 2.63× | 2.57× | ||
| Q2 24 | 59.35× | 4.20× | ||
| Q1 24 | -6.24× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LCNB
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
